| Literature DB >> 29900173 |
VijayKumar Patra1,2,3, Léo Laoubi1, Jean-François Nicolas1,4, Marc Vocanson1, Peter Wolf3.
Abstract
The human skin is known to be inhabited by diverse microbes, including bacteria, fungi, viruses, archaea, and mites. This microbiome exerts a protective role against infections by promoting immune development and inhibiting pathogenic microbes to colonize skin. One of the factors having an intense effect on the skin and its resident microbes is ultraviolet-radiation (UV-R). UV-R can promote or inhibit the growth of microbes on the skin and modulate the immune system which can be either favorable or harmful. Among potential UV-R targets, skin resident memory T cells (TRM) stand as well positioned immune cells at the forefront within the skin. Both CD4+ or CD8+ αβ TRM cells residing permanently in peripheral tissues have been shown to play prominent roles in providing accelerated and long-lived specific immunity, tissue homeostasis, wound repair. Nevertheless, their response upon UV-R exposure or signals from microbiome are poorly understood compared to resident TCRγδ cells. Skin TRM survive for long periods of time and are exposed to innumerable antigens during lifetime. The interplay of TRM with skin residing microbes may be crucial in pathophysiology of various diseases including psoriasis, atopic dermatitis and polymorphic light eruption. In this article, we share our perspective about how UV-R may directly shape the persistence, phenotype, specificity, and function of skin TRM; and moreover, whether UV-R alters barrier function, leading to microbial-specific skin TRM, disrupting the healthy balance between skin microbiome and skin immune cells, and resulting in chronic inflammation and diseased skin.Entities:
Keywords: immune suppression; inflammation; photomedicine; phototherapy; skin microbiome; skin resident memory T cells; ultraviolet-radiation
Year: 2018 PMID: 29900173 PMCID: PMC5988872 DOI: 10.3389/fmed.2018.00166
Source DB: PubMed Journal: Front Med (Lausanne) ISSN: 2296-858X
Figure 1UV-induced events in the skin: Both UV-B (290–320 nm) and UV-A (320–400 nm) penetrate the skin. UV-B causes sunburn and DNA damage and is also known to induce immune suppression. UV-B and UV-A (to some extent) converts trans-UCA to cis-UCA and generates free radicals. Commensal microbiome colonizes the skin and can induce production of various cytokines, antimicrobial peptides (AMPs) and activate toll-like receptors (TLRs). The effects of UV-B and UV-A on skin microbiome is not fully understood. Overall, UV-R is known to activate innate immunity by production of AMPs and by stimulating innate cells like macrophages, mast cells, innate lymphoid cells (ILCs) and skin resident γδ T cells. On the other hand, UV-R induces an immune suppressive environment in the skin by inducing production of TNF, IL-4, IL-10. As overall result, regulatory T cells (Tregs) and B cells (Bregs) are induced leading to functional immune suppression and subsequent inhibition of effector T cells present in the skin. Regarding TCRαβ+ lymphocytes, effector memory T cells (TEM) can circulate between the blood, lymph and skin where they receive environmental signals. Also, the dermis is populated by CD4+ TRM (CD69+ CD103±) whereas the epidermis is composed of CD8+ TRM (CD69+CD103±) in majority. These TRM populations can produce TNF-α, IL-2 and IFN-γ depending on the microenvironment. Nevertheless, the UV effect on these TRM remains to uncovered.
Figure 2Interplay of UV-R, skin microbiome and skin resident memory TCRαβ+ cells: (1) UV-R induces keratinocytes and other skin cells to produce inflammatory or regulatory cytokines that will influence TRM phenotype, retention and reactivation. (2) UV-R modulates microbial landscape, eventually releasing microbial antigens into the skin that will be up taken by dendritic cells (DC) that will specifically activate TRM (regulatory or effector). Microbial antigens can also trigger the production of inflammatory cytokines by keratinocytes that further activate TRM. (3) High doses of UV-R can cause barrier disruption that will allow skin resident microbes to enter the skin; danger signals from barrier disruption (3a) and microbes entered into the skin (3b) will trigger cytokines production by keratinocytes, DCs, ILCs, NK and TCRγδ cells. Those cytokines will take part in shaping TRM phenotype and activation. Entered microbes can also activate skin TRM in a specific manner (3c) or be uptaken by DCs (3d) in order to activate naïve specific T cells in draining lymph nodes that will be recruited on the site.